Parkinsonian signs and substantia nigra neuron density in decendents elders without PD
暂无分享,去创建一个
C. Tanner | W. Markesbery | D. Davis | L. Launer | R. Abbott | L. White | G. Ross | K. Masaki | H. Petrovitch | J. Nelson | J. Hardman | G. Ross
[1] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[2] S. Syme,et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. , 1974, Journal of chronic diseases.
[3] P. W. Lane,et al. Analysis of covariance and standardization as instances of prediction. , 1982, Biometrics.
[4] Daniel L. McGee,et al. Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics. , 1984, American journal of epidemiology.
[5] L. Heilbrun,et al. The origins of epidemiologic studies of heart disease, cancer and osteoporosis among Hawaii Japanese. , 1985, Hawaii medical journal.
[6] P. Lewitt,et al. Motor function in the normal aging population: treatment with levodopa. , 1985, Neurology.
[7] Diane C. Tsai. Recent Developments in Parkinson's Disease , 1986, The Yale Journal of Biology and Medicine.
[8] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[9] C. Ward,et al. Research diagnostic criteria for Parkinson's disease. , 1990, Advances in neurology.
[10] Ward Cd,et al. Research diagnostic criteria for Parkinson's disease. , 1990 .
[11] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[12] S. Kish,et al. Aging Produces a Specific Pattern of Striatal Dopamine Loss: Implications for the Etiology of Idiopathic Parkinson's Disease , 1992, Journal of neurochemistry.
[13] J. H. Schuenemeyer,et al. Generalized Linear Models (2nd ed.) , 1992 .
[14] J. Langston,et al. Aging and the nigrostriatal dopamine system: a non-human primate study. , 1994, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[15] E. Teng,et al. The Cognitive Abilities Screening Instrument (CASI): A Practical Test for Cross-Cultural Epidemiological Studies of Dementia , 1994, International Psychogeriatrics.
[16] Eileen O. Smith,et al. Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's disease , 1995, Annals of neurology.
[17] D. Charney,et al. Age-Related Decline in Striatal Dopamine Transporter Binding with Iodine-123-β-CITSPECT , 1995 .
[18] J. Rinne,et al. Cell counts in the substantia nigra: a comparison of single section counts and disector counts in patients with Parkinson's disease and in controls , 1995, Neuropathology and applied neurobiology.
[19] D. Morens,et al. Epidemiologic observations on Parkinson's disease , 1996, Neurology.
[20] L A Beckett,et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. , 1996, The New England journal of medicine.
[21] D J Foley,et al. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. , 1996, JAMA.
[22] J. Rinne,et al. Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts , 1997, Journal of the Neurological Sciences.
[23] Y. Stern,et al. Pathological correlates of extrapyramidal signs in Alzheimer's disease , 1997, Annals of neurology.
[24] D. Davis,et al. Microscope field size and the neuropathologic criteria for Alzheimer's disease , 1997, Neurology.
[25] J. Holden,et al. Age‐related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys , 1998, The Journal of comparative neurology.
[26] B T Hyman,et al. Stereology: A Practical Primer for Neuropathology , 1998, Journal of neuropathology and experimental neurology.
[27] R. Prettyman. Extrapyramidal signs in cognitively intact elderly people. , 1998, Age and ageing.
[28] A. Graybiel,et al. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.
[29] K. Jellinger. Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms? , 1999, Journal of neural transmission. Supplementum.
[30] A. Graybiel,et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.
[31] C. Tanner,et al. Association of coffee and caffeine intake with the risk of Parkinson disease. , 2000, JAMA.
[32] A. Bonnet. [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.
[33] G. Gerhardt,et al. Dopaminergic therapy improves upper limb motor performance in aged rhesus monkeys , 2000, Annals of neurology.
[34] E. Wolters,et al. Imaging of dopamine transporters with [123I]FP‐CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease , 2001, Synapse.
[35] Eric R. Ziegel,et al. Generalized Linear Models , 2002, Technometrics.
[36] J. Seibyl,et al. Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[37] J. Touchon,et al. Mild extrapyramidal signs and functional impairment in ageing , 2002, International journal of geriatric psychiatry.
[38] Chris Zarow,et al. Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis , 2003, Neurobiology of Aging.
[39] Chris Zarow,et al. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. , 2003, Archives of neurology.